The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Medicamen Biotech Ltd

Medicamen Biotech Ltd

BSE 531146 · NSE MEDICAMEQ · ISIN INE646B01010 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹229.60

-4.45%

BSE close, 28 August 2026

Market cap

₹311.40 cr

1.4 cr shares · Micro cap

Free float

₹175.32 cr

as published

P/E · P/B

30.2× · 1.41×

EPS ₹7.59 · BV ₹162.84

FY25-26 rev / PAT

178.85 / 9.41

₹ cr, as filed

Filings, window

14

1 selected · 7%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹210.10 52-WK HIGH ₹454.00 ₹229.60 8% of range
Against 52-week high-49.4%
Against 52-week low+9.3%
Day change-4.45%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹7.59
Price / earnings30.25×
Price / book1.41×
Book value — derived, price ÷ P/B₹162.84
Return on equity4.67%
Operating margin12.86%
Net margin5.76%

Consistency check

P/B ÷ P/E, which must equal ROE
4.66%
ROE as published
4.67%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 43.85 2.53 1.86 12.86% 5.76%
Mar-26 · Q 54.68 2.97 2.19 10.71% 5.44%
FY25-26 178.85 9.41 6.94 11.96% 5.26%

Quarter on quarter

Revenue, quarter on quarter
-19.8%
Net profit, quarter on quarter
-14.8%
Operating margin, quarter on quarter
+215 bps

Disclosure profile 14 filings in the window

0 median 17.0 p75 · 25 sector max 52 14 39th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Results1
Selected sub-total1
Procedural
AGM / EGM2
Record Date2
Annual Report1
BRSR1
Board Meeting1
Book Closure1
Compliance Certificate1
General1
Newspaper Publication1
PIT / Insider Policy1
Trading Window1
Procedural sub-total13
Total14

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

14 filings · 1 selected · busiest 2026-09-03

Filing rhythm · the twelve most recent

2026-08-142026-09-30

SelectedProcedural

Filings

14 in the window · 1 earlier on record

  1. 30 September 2026 ·

    PIT / Insider Policy

    Trading Plan under SEBI (PIT) Regulations, 2015

    Trading Plan under SEBI (PIT) Regulations 2015 - Mr Sanjay Bansal

    Company Update / Trading Plan under SEBI (PIT) Regulations, 2015 View filing →

  2. 28 September 2026 ·

    General

    Voting Reults Of 33Rd Annual General Meeting - September 26, 2026

    Voting Results of 33rd Annual General Meeting - September 26, 2026

    Company Update / General View filing →

  3. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of Trading Window- Septemeber 30, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 3 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Reg 34 (1) Annual Report

    Others / Reg. 34 (1) Annual Report View filing →

  5. 3 September 2026 ·

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Business Responsibilty and Sustainability Report - 2025-26

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  6. 3 September 2026 ·

    AGM / EGM

    Annual Report 2025-26

    Submission of Integrated Annual Report for FY 2025-26

    AGM/EGM / AGM View filing →

  7. 3 September 2026 ·

    AGM / EGM

    Notice Of 33Rd Annual General Meeting - September 26, 2026

    Notice of 33rd AGM scheduled to be held on Saturday, September 26, 2026 through video conferencing/other audio visual means ("VC/OAVM")

    AGM/EGM / AGM View filing →

  8. 18 August 2026 ·

    Record Date

    Intimation Of Book Clsoure And Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligationa And Disclosure Requirements) Regulation 2015

    The Company has fixed Saturday, September 19, 2026 as the record date for determining the entitlement of members to receive the dividend, if declared at the ensuing AGM.

    Corp. Action / Record Date View filing →

  9. 17 August 2026 ·

    Record Date

    Corpoarte Action - Fixes Record Date As September 19, 2026 For The Purpose Of Declaration Of Final Dividend For The FY 2025-26.

    Corporate Action- Fixes Record Date as September 19, 2026 for the purpose of declaration of final dividend for FY 2025-26.

    Corp. Action / Record Date View filing →

  10. 17 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Announcement under Regulation 30 (LODR)- Newspaper Publication for the Unaudited Standalone and Consolidated Financial Results for the Qtr ended 30.06.2026

    Company Update / Newspaper Publication View filing →

  11. 14 August 2026 ·

    Book Closure

    Closure Of Register Of Members And Share Transfer Books

    Board of Directors has been approved the closure of Register of Members and Share Transfer Books from September 19, 2026 to September 25, 2026 in connection with the proposed payment of ....

    Corp. Action / Book Closure View filing →

  12. 14 August 2026 ·

    Results

    Financial Results For The Quarter Ended On June 30, 2026.

    Financial Results for the quarter ended on June 30, 2026.

    Result / Financial Results View filing →

  13. 7 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended 30 June 2026.

    Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

    Board Meeting / Board Meeting View filing →

  14. 28 July 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

RSS feed for Medicamen Biotech Ltd · the 50 most recent filings